Combo GIP/GLP-1 Injectable Beats Insulin for A1c Reduction

(MedPage Today) -- An investigational antidiabetic agent proved both non-inferior and superior to insulin for type 2 diabetes management, according to findings of the phase III SURPASS-3 trial.
Over the course of the 52-week trial, all three doses...